Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04646382Not ApplicableCompleted

Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels

Role: lead

NCT05016999Not ApplicableCompleted

Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers.

Role: lead

NCT04647071Not ApplicableCompleted

Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers

Role: lead

All 3 trials loaded